CTRI/2016/12/007585招募中2 期
Phase II randomized Controlled trial of postoperative Intensity modulated Radiotherapy (IMRT) in locally Advanced Thyroid Cancers. - THYRO-RT
Tata Memorial Hospital Intramural fundin0 个研究点目标入组 72 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •A) All patients of thyroid cancer (papillary/follicular/poorly differentiated) who have undergone total/completion thyroidectomy at our institute and having at least two of the following features (listed below) intra-operatively and/or on histopathology
- •1.Gross extrathyroidal spread into soft tissues of the neck, trachea, esophagus, recurrent laryngeal nerve (constituting stage T4a)
- •2.R1/ shave resections (minimal residual disease)
- •3.R2 resections (gross residual disease)
- •4.Multiple lymph nodes positive( >2) with perinodal extension at level VI
- •B) Normal baseline haematological and biochemical parameters
排除标准
- •1.Anaplastic or medullary thyroid cancer
- •2.Previous history of radiation
- •3.Pregnancy
- •4. < 18 years
- •5.Patient unwilling to participate in the study
研究者
相似试验
招募中
2 期
Phase II randomised controlled trial of patient-specific adaptive versus continuous Abiraterone or eNZalutamide in metastatic castration-resistant prostate cancer: the ANZadapt studyprostate carcinoma10038597prostate cancerNL-OMON56330eids Universitair Medisch Centrum84
尚未招募
不适用
A Randomised controlled trial of infraclavicular versus costoclavicular approach of Infraclavicular block in upper limb surgeryCTRI/2021/08/035491ady hardinge medical college
已完成
不适用
Enhancing decision-making about treatment in bipolar II disorder: Evaluation of a treatment decision-aid for patients and their family.Bipolar II disorderMental Health - Other mental health disordersACTRN12617000840381A/Prof Ilona Juraskova196
招募中
2 期
The ProCare Trial: A randomised controlled trial of follow up of men with prostate cancer in primary care.Cancer - ProstateProstate cancerACTRN12610000938000Primary Care Collaborative Cancer Clinical Trials Group188
尚未招募
2 期
To determine whether the intensification of treatment in the form of chemotherapy and EGFR TKI gefitinib) combination increases survival among a â??high riskâ?? sub population of patients with lung cancer who have an EGFR mutatioCTRI/2022/02/040621CMC Vellore